HMNEX Co., Ltd. (KOSDAQ:036170)
3,300.00
+250.00 (8.20%)
At close: Mar 6, 2026
HMNEX Revenue
In the year 2022, HMNEX had annual revenue of 13.42B KRW, down -15.39%. HMNEX had revenue of 11.31B in the quarter ending September 30, 2025, with 226.59% growth.
Revenue
13.42B
Revenue Growth
-15.39%
P/S Ratio
14.82
Revenue / Employee
291.71M
Employees
46
Market Cap
198.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 13.42B | -2.44B | -15.39% |
| Dec 31, 2021 | 15.86B | 2.28B | 16.83% |
| Dec 31, 2020 | 13.57B | 84.95M | 0.63% |
| Dec 31, 2019 | 13.49B | -924.37M | -6.41% |
| Dec 31, 2018 | 14.41B | -2.18B | -13.14% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| New Power Plasma | 567.65B |
| Dong A Eltek | 396.06B |
| Avaco | 339.60B |
| DMS Co.,Ltd. | 199.65B |
| HyVision System. | 193.16B |
| C&G Hi Tech | 183.90B |
| Keeps Biopharma | 157.75B |
| HB Technology CO.,LTD. | 137.50B |